Exploring the Potential of a P2X3 Receptor Antagonist: Gefapixant in the Management of Persistent Cough Associated with Interstitial Lung Disease.

Medicina (Kaunas) · 2025 · PMC12112830 · PMID 40428850

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the number of patients in this study was small and did not reach statistical significance, it is likely that similar results to those of these clinical trials would be obtained in real clinical cases.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.